News

New study describes CRISPR-assisted nano droplet differential identification (CANDI) platform that enables rapid and specific detection of 15 Mycobacterium species and subspecies in clinical specimens.

Ellen Risemberg (Dr. William Valdar lab) has published a paper in Genetics titled "Systems genetics analysis reveals immune mediators of coronavirus disease severity in mice".

Department of Genetics faculty, postdocs, students and collaborators published 32 papers in August 2026.

Dr. Shawn O’Neil has been promoted to Associate Professor in the Department of Genetics, effective October 1, 2026.  

Dr. Charles Perou, May Goldman Shaw Distinguished Professor of Molecular Oncology, Professor in the Department of Genetics and Pathology & Laboratory Medicine, Co-Director of the Computational Medicine Program, Faculty Director of the Lineberger Comprehensive Cancer Center Bioinformatics Group, and Co-Director of the LCCC Breast Cancer Research Program, was honored at...

The study offers new insight into how genetic changes affect the structure of the human cortex, a brain region important for thinking and memory.

UNC Bioinformatics and Computational Biology graduate student Luvna Dhawka (Natalie Stanley lab) has been awarded a 2026 Diana Jacobs Kalman/AFAR Graduate Student Award in Geroscience. This $5,000 award recognizes PhD students who have shown leadership, collaboration, and productivity in aging research. Luvna’s work uses computational single-cell methods to study how...

Dr. Hyejung Won (Associate Professor, Department of Genetics and UNC Neuroscience Center) was awarded a new R01 grant from the National Institute of Mental Health (NIMH) for her project titled “Interplay between common and rare variants associated with schizophrenia”.

The international research effort created hundreds of patient-derived cancer models that closely reflect the molecular features of patients’ original tumors. Katherine A. Hoadley, PhD, a cancer genomics researcher at the UNC Lineberger Comprehensive Cancer Center, helped analyze data and plan and oversee a large international study that created one of...

Alex Rubinsteyn and Dr. Benjamin Vincent are gathering clinical data to train AI models that can identify stronger cancer-cell targets and guide the development of more precise, personalized vaccines.